Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Not Confirmed
Not Confirmed
11-13 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Industry Trade Show
Not Confirmed
11-13 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities
09 Dec 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/first-in-class-investigational-sx-682-demonstrates-single-agent-efficacy-in-patients-with-hypomethylating-agent-failure-myelodysplastic-syndromes-301699265.html
26 Oct 2020
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/syntrix-completes-initial-sx-682-dosing-in-broad-phase-12-cancer-trial-campaign-now-encompassing-5-solid-cancer-types-plus-myelodysplastic-syndromes-301160630.html
04 Feb 2020
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/syntrix-discovers-desmetramadol-is-g-protein-biased-opioid-receptor-agonist-300998555.html
31 Oct 2019
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/syntrix-pharmaceuticals-to-present-positive-desmetramadol-trial-results-at-the-2019-pain-management-summit-300949283.html
04 Jun 2019
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/syntrix-pharmaceuticals-announces-publication-of-positive-double-blind-clinical-trials-showing-desmetramadol-has-the-analgesic-and-side-effect-profile-of-tramadol-without-its-metabolic-liabilities-300861610.html
04 Feb 2019
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/syntrix-wins-3-4m-nih-grant-to-conduct-phase-12-trial-of-sx-682-in-myelodysplastic-syndrome-300788624.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?